We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$30.1B
AUM Growth
+$1.02B
Cap. Flow
-$1.16B
Cap. Flow %
-3.87%
Top 10 Hldgs %
22.79%
Holding
1,200
New
104
Increased
364
Reduced
497
Closed
122

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$50.1M
2
CSCO icon
Cisco
CSCO
+$39.1M
3
EW icon
Edwards Lifesciences
EW
+$38.9M
4
ETN icon
Eaton
ETN
+$37.7M
5
BAC icon
Bank of America
BAC
+$36.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$92.9M
2
TXN icon
Texas Instruments
TXN
+$67.4M
3
PFE icon
Pfizer
PFE
+$57.7M
4
FIS icon
Fidelity National Information Services
FIS
+$56.9M
5
TSLA icon
Tesla
TSLA
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 33.71%
2 Healthcare 19.22%
3 Consumer Discretionary 11.87%
4 Financials 8.66%
5 Industrials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFIX
826
Stitch Fix
SFIX
$392M
$839K ﹤0.01%
217,800
ALL icon
827
Allstate
ALL
$65B
$837K ﹤0.01%
7,673
+1,979
+35% +$224K
TVTX icon
828
Travere Therapeutics
TVTX
$5.89B
$823K ﹤0.01%
53,600
-299,187
-85% -$5.44M
LDOS icon
829
Leidos
LDOS
$16.2B
$822K ﹤0.01%
9,285
-63
-0.7% -$5.37K
PNC icon
830
PNC Financial Services
PNC
$96.1B
$820K ﹤0.01%
6,512
-64,939
-91% -$7.94M
LXRX icon
831
Lexicon Pharmaceuticals
LXRX
$894M
$816K ﹤0.01%
356,400
RMR icon
832
The RMR Group
RMR
$327M
$815K ﹤0.01%
35,178
-2,900
-8% -$67.7K
EQH icon
833
Equitable Holdings
EQH
$14.7B
$815K ﹤0.01%
30,003
-142,392
-83% -$3.6M
WOW
834
DELISTED
WideOpenWest
WOW
$810K ﹤0.01%
96,000
+1,700
+2% +$15.4K
TREE icon
835
LendingTree
TREE
$376M
$807K ﹤0.01%
+36,500
New +$778K
SAIC icon
836
Saic
SAIC
$5.6B
$807K ﹤0.01%
7,172
+1,800
+34% +$187K
PPG icon
837
PPG Industries
PPG
$23.3B
$805K ﹤0.01%
5,427
+2,768
+104% +$386K
ROVR
838
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$802K ﹤0.01%
+163,400
New +$747K
POR icon
839
Portland General Electric
POR
$5.58B
$801K ﹤0.01%
17,100
+800
+5% +$39.6K
AA icon
840
Alcoa
AA
$12.3B
$800K ﹤0.01%
23,590
-8,372
-26% -$304K
ESS icon
841
Essex Property Trust
ESS
$17.7B
$797K ﹤0.01%
3,403
+1,056
+45% +$231K
CASH icon
842
Pathward Financial
CASH
$1.65B
$788K ﹤0.01%
17,000
-5,600
-25% -$251K
KB icon
843
KB Financial Group
KB
$45.5B
$776K ﹤0.01%
21,307
INGN icon
844
Inogen
INGN
$138M
$773K ﹤0.01%
+66,900
New +$788K
QVCGA
845
DELISTED
QVC Group Inc Series A
QVCGA
$767K ﹤0.01%
+15,508
New +$698K
ASO icon
846
Academy Sports + Outdoors
ASO
$3.11B
$762K ﹤0.01%
14,100
-50,200
-78% -$2.88M
KBH icon
847
KB Home
KBH
$3.04B
$755K ﹤0.01%
+14,600
New +$659K
PAAS icon
848
Pan American Silver
PAAS
$20.1B
$751K ﹤0.01%
+51,534
New +$851K
TGB
849
Trekor Metals
TGB
$2.92B
$746K ﹤0.01%
+521,500
New +$780K
CTRA
850
DELISTED
Coterra Energy
CTRA
$731K ﹤0.01%
28,883
+1,502
+5% +$37.3K

Similar funds

Axa's Q2 2023 Portfolio in Review

As of Q2 2023, Axa held 1,200 positions worth $30.1B, up 3.5% from $29.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa withdrew a net $1.16B in Q2 2023, closing 122 positions and reducing 497 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Lincoln Electric worth $19.9M.

  • Axa's largest Q2 2023 buy was Lincoln Electric: 100,054 shares worth $19.9M.
  • Axa added most to Intuit in Q2 2023, an estimated $50.1M increase.
  • Axa's biggest Q2 2023 reduction was Apple, cutting an estimated $92.9M.
  • Axa fully exited Vanguard S&P 500 ETF in Q2 2023, selling an estimated $44.8M.
  • Axa's ten largest holdings make up 23% of its $30.1B portfolio in Q2 2023.
  • Axa opened 104 new positions and closed 122 in Q2 2023.
  • Axa's portfolio value rose 3.5% quarter-over-quarter to $30.1B.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.